PDE5A and cardiovascular disorder: The early findings thus pointed to PDE9A as a novel therapeutic target in cardiovascular disease, distinct from the well-known PDE5A, by suggesting that blocking PDE9A could augment NP/cGMP signaling and mitigate cardiac stress responses [10].